This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Heparin
and you are
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a prospective randomized clinical trial about the efficacy of heparin nebulization on lung injury score in inhalation burn injury in Mothary burn hospital. This study would consist of 170 burn patients with documented inhalation injury in 2 arms (control group and study group). Allocation ratio is1:1. Masking was not possible. The patients' primary outcome will be assessed for Lung Injury Scale and the patients' secondary outcome will be assessed for mortality, Coagulation tests (PT, PTT), ICU and hospital stay and duration of mechanical ventilation support. Duration of this study is about 32 months.

Provided treatments

  • Drug: standard care
  • Drug: Heparin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01454869. The sponsor of the trial is Tehran University of Medical Sciences and it is looking for 0 volunteers for the current phase.
Official trial title:
Efficacy of Heparin Nebulization on Lung Injury Score in Inhalation Burn Injury